TOPICAL ANALGESICS: CHOOSING THE PROPER MEDICATION
JEFFREY GUDIN, MD
Professor of Medicine
Department of Anesthesiology, Perioperative Medicine and Pain Management
University of Miami Miller School of Medicine
Miami, FL
ADVERTISMENT
OTHER RECOMMENDED VIDEOS
 |
Patient Expectations and Goal Setting
JEREMY A. ADLER, DMSC, PA-C
|
 |
BEST PRACTICES IN PAIN MANAGEMENT
JEFFREY GUDIN, MD
|
 |
USING EVIDENCE-BASED MEDICAL MANAGEMENT WHEN CHOOSING TOPICAL THERAPIES
CHARLES ARGOFF, MD
|
 |
ASSESSMENT AND DIAGNOSIS OF THE PAIN PATIENT: EVALUATING THE WHOLE PATIENT
STEVEN STANOS, DO
|
 |
Where do OTC Treatments Fit Into Practice?
JEREMY A. ADLER, DMSC, PA-C
|
 |
APPROPRIATE PATIENTS FOR TOPICAL THERAPY: IMPORTANT CONSIDERATIONS
CHARLES ARGOFF, MD
|
 |
The Expanding Role of the NP/PA in Practice
THERESA (TRACEY) MALLICK-SEARLE, MS, PMGT-BC, ANP-BC
|
 |
ACP/ACR/AAFP GUIDELINE UPDATES: A PERSON CENTERED APPROACH TO CARE
STEVEN STANOS, DO
|
 |
TOPICAL ANALGESICS: THE IMPORTANCE OF FDA APPROVAL
STEVEN STANOS, DO
|
 |
NSAIDS: Differentiating Oral vs. Topical
Chris J. Kottenstette, PA-C, CPE
|
 |
Future Opportunities in the Pain Management Field
JEREMY A. ADLER, DMSC, PA-C
|
 |
Best Practices in Pain Management: Minimizing Risk through Rational Polypharmacy
Chris J. Kottenstette, PA-C, CPE
|
 |
OTC Topical Analgesics: Cutting Through the Noise
THERESA (TRACEY) MALLICK-SEARLE, MS, PMGT-BC, ANP-BC
|
 |
TOPICAL ANALGESICS: UNDERSTANDING THE MOA TO MAKE PROPER TREATMENT DECISIONS
STEVEN STANOS, DO
|
 |
ACP/AAFP Guideline Updates for Musculoskeletal Pain
Chris J. Kottenstette, PA-C, CPE
|
 |
Topical Analgesics: Updates to Clinical Guidelines
THERESA (TRACEY) MALLICK-SEARLE, MS, PMGT-BC, ANP-BC
|
 |
THE IMPORTANCE OF FDA APPROVAL OF TOPICAL MEDICATIONS
JEFFREY GUDIN, MD
|
 |
Topical Medications: Understanding Side Effects of Treatment
JEREMY A. ADLER, DMSC, PA-C
|
 |
THE CHANGING PAIN MANAGEMENT LANDSCAPE
CHARLES ARGOFF, MD
|
 |
TOPICAL ANALGESICS: CHOOSING THE PROPER MEDICATION
JEFFREY GUDIN, MD
|
 |
ACP AND AAFP GUIDELINE UPDATES FOR PAIN - WHERE DO TOPICALS FIT IN?
JEFFREY GUDIN, MD
|
 |
NSAIDS: Understanding Common and Uncommon Risks
Chris J. Kottenstette, PA-C, CPE
|
 |
Safety and Efficacy of Over the Counter Products: The Importance of FDA Approval
Chris J. Kottenstette, PA-C, CPE
|
 |
PROPOSED NEW LOW-DOSE ASPIRIN GUIDELINES: A REVIEW OF ORAL NSAIDS
JEFFREY GUDIN, MD
|
 |
Importance of FDA Approval for Topical Therapies
JEREMY A. ADLER, DMSC, PA-C
|
 |
The Changing Landscape in Pain Management
THERESA (TRACEY) MALLICK-SEARLE, MS, PMGT-BC, ANP-BC
|
 |
Treatment Decisions: Understanding the Rehabilitative Model vs. Palliative Model
JEREMY A. ADLER, DMSC, PA-C
|
 |
DIFFERENTIATING RISK BETWEEN ORAL AND TOPICAL MEDICATIONS- BACKED BY SCIENCE
JEFFREY GUDIN, MD
|
 |
Proposed Guideline Changes for Low-Dose Aspirin for Primary Prevention of Cardiovascular Disease (CVD)
Chris J. Kottenstette, PA-C, CPE
|
 |
Best Practices in Pain Management for Frontline Clinicians
THERESA (TRACEY) MALLICK-SEARLE, MS, PMGT-BC, ANP-BC
|
 |
INCORPORATING TOPICAL THERAPIES AS PART OF A MULTI- MODAL TREATMENT APPROACH
CHARLES ARGOFF, MD
|
 |
THE CHANGING PAIN MANAGEMENT LANDSCAPE
JEFFREY GUDIN, MD
|
 |
RISK MITIGATION STRATEGIES: UNDERSTANDING INTERPATIENT VARIABILITY
STEVEN STANOS, DO
|
 |
NSAIDS: Risk Mitigation Strategies
THERESA (TRACEY) MALLICK-SEARLE, MS, PMGT-BC, ANP-BC
|
 |
Proper Patient Assessment, Diagnosis, and Treatment
JEREMY A. ADLER, DMSC, PA-C
|
ADVERTISMENT